Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06298357 · ClinicalTrials.gov registry record · Phase 1
Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation
A Phase 1 study of Pediatric Cancer, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT06298357 is a Phase 1 study of Pediatric Cancer that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 11 participants, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06298357, a Phase 1 study of Pediatric Cancer, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will explore the potential benefits of a virtual reality gaming program that focuses on mindfulness and exercise among pediatric cancer rehabilitation patients. The program will last 8 weeks outside of the hospital. Participants will start immediately in the hospital (immediate start group) or wait 8 weeks after hospital discharge to start the program (waitlist control group).
Conditions Studied
Interventions
- BEHAVIORAL Immediate Start - Virtual Reality
- BEHAVIORAL Delayed Start - Virtual Reality
Study Locations (1)
Alabama
- Children's Hospital of Alabama - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-06-27 |
| Est. Completion | 2026-03-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06298357
The ClinicalTrials.gov registry entry for NCT06298357 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pediatric Cancer appearing as the primary indexed condition, and to 2 interventions - of which Immediate Start - Virtual Reality is the first listed.
NCT06298357 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT06298357 about?
NCT06298357 is a clinical study titled "Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation". This study will explore the potential benefits of a virtual reality gaming program that focuses on mindfulness and exercise among pediatric cancer rehabilitation patients. The program will last 8 weeks outside of the hospital. Participants will start immediately in the hospital (immediate start grou...
What is the current status of trial NCT06298357?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2024-06-27. Estimated completion is 2026-03-16.
What conditions does trial NCT06298357 study?
This clinical trial studies the following conditions: Pediatric Cancer.
What interventions are being tested in trial NCT06298357?
The interventions under investigation include: Immediate Start - Virtual Reality (BEHAVIORAL), Delayed Start - Virtual Reality (BEHAVIORAL).
Who is sponsoring clinical trial NCT06298357?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06298357 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
RECRUITING · Phase 1
-
Lurbinectedin in FET-Fused Tumors
RECRUITING · Phase 1
-
Durvalumab and Tremelimumab for Pediatric Malignancies
ACTIVE NOT RECRUITING · Phase 1
-
LIFE Cancer Survivorship Database for Pediatric Cancer
RECRUITING
-
Multisite Implementation of COMPRENDO
RECRUITING · NA
-
Childhood Cancer Predisposition Study (CCPS)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.